Skip to main content

Ketamine Injection Shortage

Last Updated: July 15, 2024
Status: Current

Products Affected - Description
    • Ketalar injection, Par Pharmaceuticals, 10 mg/mL, 20 mL vial, 10 count, NDC 42023-0113-10
    • Ketalar injection, Par Pharmaceuticals, 100 mg/mL, 5 mL vial, 10 count, NDC 42023-0115-10
    • Ketalar injection, Par Pharmaceuticals, 50 mg/mL, 10 mL vial, 10 count, NDC 42023-0114-10
    • Ketamine injection, Eugia US, 100 mg/mL, 10 mL vial, 10 count, NDC 55150-0440-10
    • Ketamine injection, Eugia US, 50 mg/mL, 10 mL vial, 10 count, NDC 55150-0439-10
    • Ketamine injection, Hikma, 100 mg/mL, 5 mL vial, 10 count, NDC 00143-9509-10
    • Ketamine injection, Hikma, 50 mg/mL, 10 mL vial, 10 count, NDC 00143-9508-10
    • Ketamine injection, Pfizer, 50 mg/mL, 10 mL vial, 10 count, NDC 00409-2053-10
    • Ketamine injection, Sagent, 10 mg/mL, 20 mL vial, 10 count, NDC 25021-0682-20
Reason for the Shortage
    • AuroMedics (Eugia) has ketamine on shortage due to increased demand.
    • Hikma has ketamine injection on back order due to shortage of active ingredient.
    • Mylan Institutional divested ketamine to AuroMedics.
    • Par has Ketalar on back order due to shortage of active ingredient.
    • Pfizer has ketamine on shortage due to manufacturing delays.
    • Sagent did not provide a reason for the shortage.
Available Products
    • Ketamine injection, Eugia US, 10 mg/mL, 20 mL vial, 10 count, NDC 55150-0438-10
    • Ketamine injection, Pfizer, 100 mg/mL, 5 mL vial, 10 count, NDC 00409-2051-05
    • Ketamine injection, Sagent, 100 mg/mL, 5 mL vial, 10 count, NDC 25021-0684-05
    • Ketamine injection, Sagent, 50 mg/mL, 10 mL vial, 10 count, NDC 25021-0683-10

Estimated Resupply Dates

    • Eugia has ketamine 50 mg/mL 10 mL vials and 100 mg/mL 10 mL vials on long-term back order and the company cannot estimate a release date.
    • Hikma has ketamine 100 mg/mL 5 mL vials on allocation. The 50 mg/mL 10 mL vials are on back order and the company estimates a release date of mid-July 2024.
    • Pfizer has ketamine 50 mg/mL 10 mL vials on back order and the company estimates a release date of January 2025.
    • Sagent has ketamine 10 mg/mL 20 mL vials on back order and the company estimates a release date of August 2024.
    • Par has all Ketalar presentations on long-term back order and the company cannot estimate a release date.

Alternative Agents & Management

    • There are practice guidelines available for moderate procedural sedation and analgesia. These are available at https://pubs.asahq.org/anesthesiology/article/128/3/437/18818/Practice-Guidelines-for-Moderate-Procedural.

Updated

Updated July 15, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.